A cost effectiveness analysis of solifenacin compared with extended-release tolterodine for the treatment of overactive bladder

被引：0

作者：

Kang, H. H. ^{[1
]}

Bae, J. Y. ^{[1
]}

Park, S. Y. ^{[1
]}

Sohn, H. S. ^{[1
]}

机构：

[1] Sock Myung Womens Univ, Seoul, South Korea

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)65151-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A319 / A319

页数：1

共 50 条

[41] The cost utility of solifenacin in the treatment of overactive bladder
Leona Hakkaart
Paul Verboom
Richard Phillips
Maiwenn J. Al
International Urology and Nephrology, 2009, 41 : 293 - 298
[42] Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
Kaplan, Steven A.
Roehrborn, Claus G.
Dmochowski, Roger
Rovner, Eric S.
Wang, Joseph T.
Guan, Zhonghong
UROLOGY, 2006, 68 (02) : 328 - 332
[43] Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence
Dyfrig A. Hughes
Dominique Dubois
PharmacoEconomics, 2004, 22 : 1047 - 1059
[44] Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence
Hughes, DA
Dubois, D
PHARMACOECONOMICS, 2004, 22 (16) : 1047 - 1059
[45] Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially-insured persons with overactive bladder
Ollendorf, D
Jumadilova, Z
Varadharajan, S
Girase, P
VALUE IN HEALTH, 2005, 8 (06) : A79 - A79
[46] Cost-effectiveness of tolterodine, a new treatment for symptoms of overactive bladder.
Kobelt, G
Jonsson, L
Lund, AM
JOURNAL OF UROLOGY, 1998, 159 (05): : 302 - 302
[47] Re: Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder Reply
不详
JOURNAL OF UROLOGY, 2012, 188 (06): : 2443 - 2443
[48] Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder
Bolge, Susan C.
McDonnell, Diana D.
Chen, Andrew
Wan, George J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1903 - 1912
[49] Health-related quality of life in patients with overactive bladder receiving tolterodine extended-release in Japan
Homma, Y
Kawabe, KK
JOURNAL OF UROLOGY, 2003, 169 (04): : 345 - 345
[50] Onset of efficacy of tolterodine extended release in patients with overactive bladder
Sussman, David O.
Kraus, Stephen R.
Carlsson, Martin
Guan, Zhonghong
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 777 - 781

← 1 2 3 4 5 →